NO20074262L - Anthelmintisk sammensetning - Google Patents
Anthelmintisk sammensetningInfo
- Publication number
- NO20074262L NO20074262L NO20074262A NO20074262A NO20074262L NO 20074262 L NO20074262 L NO 20074262L NO 20074262 A NO20074262 A NO 20074262A NO 20074262 A NO20074262 A NO 20074262A NO 20074262 L NO20074262 L NO 20074262L
- Authority
- NO
- Norway
- Prior art keywords
- active ingredient
- carrier
- formulation
- anthelmintic composition
- chlorosulon
- Prior art date
Links
- 230000000507 anthelmentic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 abstract 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 abstract 1
- 239000005660 Abamectin Substances 0.000 abstract 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract 1
- 241001468227 Streptomyces avermitilis Species 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229960002418 ivermectin Drugs 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960000502 poloxamer Drugs 0.000 abstract 1
- 229920001983 poloxamer Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0501220.8A GB0501220D0 (en) | 2005-01-21 | 2005-01-21 | Anthelmintic composition |
| PCT/GB2006/000211 WO2006077429A1 (en) | 2005-01-21 | 2006-01-19 | Anthelmintic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074262L true NO20074262L (no) | 2007-08-21 |
Family
ID=34259424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074262A NO20074262L (no) | 2005-01-21 | 2007-08-21 | Anthelmintisk sammensetning |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20080206378A1 (pl) |
| EP (1) | EP1838295B1 (pl) |
| JP (1) | JP5094414B2 (pl) |
| KR (1) | KR20070094979A (pl) |
| CN (1) | CN101107002B (pl) |
| AP (1) | AP2753A (pl) |
| AR (1) | AR052882A1 (pl) |
| AT (1) | ATE452628T1 (pl) |
| AU (1) | AU2006207326B2 (pl) |
| BR (1) | BRPI0606429A2 (pl) |
| CA (1) | CA2594981C (pl) |
| CR (1) | CR9259A (pl) |
| CY (1) | CY1109885T1 (pl) |
| DE (1) | DE602006011271D1 (pl) |
| DK (1) | DK1838295T3 (pl) |
| EA (1) | EA012284B1 (pl) |
| ES (1) | ES2337177T3 (pl) |
| GB (1) | GB0501220D0 (pl) |
| IL (1) | IL184737A (pl) |
| MX (1) | MX2007008750A (pl) |
| NO (1) | NO20074262L (pl) |
| NZ (1) | NZ556537A (pl) |
| PE (1) | PE20060908A1 (pl) |
| PL (1) | PL1838295T3 (pl) |
| PT (1) | PT1838295E (pl) |
| SI (1) | SI1838295T1 (pl) |
| TN (1) | TNSN07285A1 (pl) |
| UY (1) | UY29342A1 (pl) |
| WO (1) | WO2006077429A1 (pl) |
| ZA (1) | ZA200705882B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IES20070395A2 (en) * | 2006-12-05 | 2008-06-11 | Michael Hilary Burke | A process for the preparation of a stable anhydrous anthelmintic formulation |
| AU2013201461B2 (en) * | 2007-11-26 | 2015-10-29 | Boehringer Ingelheim Animal Health USA Inc. | Solvent systems for pour-on formulations for combating parasites |
| BRPI0819849B8 (pt) * | 2007-11-26 | 2021-05-25 | Merial Ltd | sistemas de solvente para formulações pour on para combater parasitas |
| GB201021836D0 (en) * | 2010-12-21 | 2011-02-02 | Norbrook Lab Ltd | Topical Composition |
| PL2844225T3 (pl) * | 2012-05-03 | 2019-07-31 | Norbrook Laboratories Limited | Formulacja awermektyny do polewania o skróconym okresie karencji |
| AR116524A1 (es) * | 2018-10-04 | 2021-05-19 | Elanco Tiergesundheit Ag | Potenciación de tratamiento de helmintos |
| AU2020231319A1 (en) * | 2019-03-01 | 2021-10-21 | Boehringer Ingelheim Animal Health USA Inc. | Injectable clorsulon compositions, methods and uses thereof |
| CN113598163A (zh) * | 2021-09-10 | 2021-11-05 | 姜兆伟 | 一种防儿童误食的蚊香液及原料苦精的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3987199A (en) * | 1973-01-26 | 1976-10-19 | Merck & Co., Inc. | Substituted benzenesulfonamides as anthelmintics |
| US4336262A (en) * | 1973-02-23 | 1982-06-22 | Fisons Ltd. | Pour-on veterinary anthelmintic |
| NL180633C (nl) * | 1973-06-22 | 1900-01-01 | Bayer Ag | Werkwijze ter bereiding van een anthelmintisch werkzaam veterinair opgiet-preparaat. |
| US3953492A (en) * | 1975-03-27 | 1976-04-27 | Merck & Co., Inc. | Anthelmintic substituted sulfonamide derivatives |
| US4065239A (en) * | 1975-10-17 | 1977-12-27 | Philip Morris, Inc. | Jam prevention device for extrusion process |
| SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| NZ207655A (en) * | 1983-04-07 | 1986-09-10 | Merck & Co Inc | Synergistic veterinary compositions containing an avermectin compound and clorsulon |
| JPH0678342B2 (ja) * | 1986-01-07 | 1994-10-05 | 三共株式会社 | 新規マクロライド化合物 |
| US5053227A (en) * | 1989-03-22 | 1991-10-01 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
| DE69432982T2 (de) * | 1993-05-10 | 2004-04-15 | Merck & Co., Inc. | Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden |
| US5602107A (en) * | 1993-05-10 | 1997-02-11 | Merck & Co., Inc. | Pour-on formulations consisting of gylcols, glycerides and avermectin compounds |
| US5773422A (en) * | 1996-01-29 | 1998-06-30 | Komer; Gene | Avermectin formulation |
| AUPQ875700A0 (en) * | 2000-07-13 | 2000-08-03 | Reflex Research Limited | Combination compositions |
| US20030064941A1 (en) * | 2001-05-21 | 2003-04-03 | Pfizer Inc. | Avermectin and praziquantel combination therapy |
| US6627613B2 (en) * | 2001-07-23 | 2003-09-30 | Michael A. Strobel | Application of water and organic solvent soluble ivermectin for topical and oral use |
| UA82359C2 (uk) * | 2003-04-03 | 2008-04-10 | Schering Plough Ltd | Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин |
| PE20050386A1 (es) * | 2003-05-29 | 2005-06-23 | Schering Plough Ltd | Composiciones farmaceuticas de florfenicol |
| GB0316377D0 (en) * | 2003-07-12 | 2003-08-13 | Norbrook Lab Ltd | Parasiticidal composition |
| US7514464B2 (en) * | 2003-12-18 | 2009-04-07 | Pfizer Limited | Substituted arylpyrazoles |
| JP4750126B2 (ja) * | 2004-11-19 | 2011-08-17 | シェーリング−プラウ・リミテッド | 殺寄生虫薬２−フェニル−３−（１ｈ−ピロール−２−イル）アクリロニトリル誘導体の使用による動物における寄生虫の制御 |
-
2005
- 2005-01-21 GB GBGB0501220.8A patent/GB0501220D0/en not_active Ceased
-
2006
- 2006-01-19 DK DK06700797.1T patent/DK1838295T3/da active
- 2006-01-19 MX MX2007008750A patent/MX2007008750A/es active IP Right Grant
- 2006-01-19 AU AU2006207326A patent/AU2006207326B2/en not_active Ceased
- 2006-01-19 AT AT06700797T patent/ATE452628T1/de active
- 2006-01-19 CN CN2006800026448A patent/CN101107002B/zh not_active Expired - Fee Related
- 2006-01-19 JP JP2007551747A patent/JP5094414B2/ja not_active Expired - Fee Related
- 2006-01-19 US US11/813,627 patent/US20080206378A1/en not_active Abandoned
- 2006-01-19 AP AP2007004083A patent/AP2753A/xx active
- 2006-01-19 KR KR1020077019118A patent/KR20070094979A/ko not_active Ceased
- 2006-01-19 EA EA200701542A patent/EA012284B1/ru not_active IP Right Cessation
- 2006-01-19 SI SI200630573T patent/SI1838295T1/sl unknown
- 2006-01-19 CA CA2594981A patent/CA2594981C/en not_active Expired - Fee Related
- 2006-01-19 EP EP06700797A patent/EP1838295B1/en not_active Revoked
- 2006-01-19 PT PT06700797T patent/PT1838295E/pt unknown
- 2006-01-19 BR BRPI0606429-9A patent/BRPI0606429A2/pt not_active Application Discontinuation
- 2006-01-19 WO PCT/GB2006/000211 patent/WO2006077429A1/en not_active Ceased
- 2006-01-19 PL PL06700797T patent/PL1838295T3/pl unknown
- 2006-01-19 DE DE602006011271T patent/DE602006011271D1/de not_active Expired - Lifetime
- 2006-01-19 NZ NZ556537A patent/NZ556537A/en not_active IP Right Cessation
- 2006-01-19 ES ES06700797T patent/ES2337177T3/es not_active Expired - Lifetime
- 2006-01-20 AR ARP060100210A patent/AR052882A1/es unknown
- 2006-01-20 PE PE2006000088A patent/PE20060908A1/es not_active Application Discontinuation
- 2006-01-23 UY UY29342A patent/UY29342A1/es not_active Application Discontinuation
-
2007
- 2007-07-18 CR CR9259A patent/CR9259A/es unknown
- 2007-07-18 ZA ZA200705882A patent/ZA200705882B/xx unknown
- 2007-07-19 IL IL184737A patent/IL184737A/en not_active IP Right Cessation
- 2007-07-20 TN TNP2007000285A patent/TNSN07285A1/en unknown
- 2007-08-21 NO NO20074262A patent/NO20074262L/no not_active Application Discontinuation
-
2010
- 2010-03-11 CY CY20101100236T patent/CY1109885T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109885T1 (el) | Ανθελμινθικη συνθεση | |
| CY1119839T1 (el) | Στερεες μορφες δοσεως μπενταμουστινης | |
| MX2010004222A (es) | Formulaciones solidas de compuestos cristalinos. | |
| BR9808581A (pt) | Estabilização de benzimidazóis sensìveis a ácido com combinações de aminoácido/ciclodextrina | |
| CY1109117T1 (el) | Διαμορφωσεις enaιωphmatoς, οι οποιες περιλαμβανουν δραστικον συστατικο, επιφανειακως δρωσαν ουσια poloxamer ή meroxapol και γλυκολη, χρησις του δια την βιομηχανικην παρασκευην φαρμακου προς νοσηλειαν οφθαλμικων διαταραχων | |
| BRPI0411171A (pt) | derivados de carboidratos de rapamicina, composição farmacêutica, método para o tratamento de uma doença tratável por rapamicina e dispositivo médico | |
| EA200870379A1 (ru) | Фармацевтическая композиция с замедленным высвобождением на основе системы высвобождения, включающей кислоторастворимый полимер и ph-зависимый полимер | |
| BRPI0418098A (pt) | formulações veterinárias não contendo produtos animais | |
| TW200621238A (en) | Pharmaceutical formulation | |
| BRPI0615860B8 (pt) | composição farmacêutica de liberação prolongada monolítica sólida | |
| AU2008282388A1 (en) | Endoparasiticidal topical compositions | |
| PH12021550477A1 (en) | Sustained-release injectable antibiotical formulation | |
| CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
| WO2007124700A3 (en) | Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof | |
| WO2007037874A3 (en) | Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear | |
| AR064152A1 (es) | Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion. | |
| US10307405B2 (en) | Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles | |
| BRPI0418427A (pt) | formulações farmacêuticas de matriz semi-sólida | |
| BRPI0506630A (pt) | composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada | |
| BRPI0510906A (pt) | composição farmacêutica tópica, composição para administração tópica e seu uso | |
| CA2622713A1 (en) | Anthelmintic formulations | |
| AU2013204176B2 (en) | Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles | |
| CL2025001049A1 (es) | Sistema de administración de ingrediente activo | |
| PE20242349A1 (es) | Composicion en espray nasal bioadhesivo, proceso de preparacion y uso | |
| EP3595441A1 (en) | Stable topical veterinary composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |